150 related articles for article (PubMed ID: 36931200)
21. Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.
Luo R; Song J; Zhang W; Ran L
Dig Dis Sci; 2020 Dec; 65(12):3538-3550. PubMed ID: 31960204
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
Gholaminejad A; Fathalipour M; Roointan A
BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
[TBL] [Abstract][Full Text] [Related]
23. mRNA-miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation.
Motieghader H; Kouhsar M; Najafi A; Sadeghi B; Masoudi-Nejad A
Mol Biosyst; 2017 Sep; 13(10):2168-2180. PubMed ID: 28861579
[TBL] [Abstract][Full Text] [Related]
24. Identification of Diagnostic Exosomal LncRNA-miRNA-mRNA Biomarkers in Colorectal Cancer Based on the ceRNA Network.
Zhao Y; Song X; Song X; Xie L
Pathol Oncol Res; 2022; 28():1610493. PubMed ID: 36185995
[No Abstract] [Full Text] [Related]
25. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis.
Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N
Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer.
Tian Y; Xing Y; Zhang Z; Peng R; Zhang L; Sun Y
Biomed Res Int; 2020; 2020():2862701. PubMed ID: 32908877
[TBL] [Abstract][Full Text] [Related]
27. Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
Wu S; Wu F; Jiang Z
Oncol Rep; 2017 Oct; 38(4):2043-2050. PubMed ID: 28902367
[TBL] [Abstract][Full Text] [Related]
28. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
[TBL] [Abstract][Full Text] [Related]
29. An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer.
Samadi P; Soleimani M; Nouri F; Rahbarizadeh F; Najafi R; Jalali A
BMC Cancer; 2022 Jul; 22(1):835. PubMed ID: 35907803
[TBL] [Abstract][Full Text] [Related]
30. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
[TBL] [Abstract][Full Text] [Related]
31. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel biomarkers affecting the metastasis of colorectal cancer through bioinformatics analysis and validation through qRT-PCR.
Lian W; Jin H; Cao J; Zhang X; Zhu T; Zhao S; Wu S; Zou K; Zhang X; Zhang M; Zheng X; Peng M
Cancer Cell Int; 2020; 20():105. PubMed ID: 32256214
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and Drug Prediction of Parkinson's Disease Based on Immune-Related Genes.
Bao J; Chang W; Zhao Y
J Mol Neurosci; 2022 Sep; 72(9):1809-1819. PubMed ID: 35731466
[TBL] [Abstract][Full Text] [Related]
34. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract][Full Text] [Related]
35. Identification of Key Genes and Circular RNAs in Human Gastric Cancer.
Hao S; Lv J; Yang Q; Wang A; Li Z; Guo Y; Zhang G
Med Sci Monit; 2019 Apr; 25():2488-2504. PubMed ID: 30948703
[TBL] [Abstract][Full Text] [Related]
36. Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.
Cao L; Chen Y; Zhang M; Xu DQ; Liu Y; Liu T; Liu SX; Wang P
PeerJ; 2018; 6():e5180. PubMed ID: 30002985
[TBL] [Abstract][Full Text] [Related]
37. Identification and Verification of Five Potential Biomarkers Related to Skin and Thermal Injury Using Weighted Gene Co-Expression Network Analysis.
Yang R; Wang Z; Li J; Pi X; Wang X; Xu Y; Shi Y; Zhou S
Front Genet; 2021; 12():781589. PubMed ID: 35047008
[No Abstract] [Full Text] [Related]
38. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
39. mRNA-miRNA bipartite networks reconstruction in different tissues of bladder cancer based on gene co-expression network analysis.
Abedi Z; MotieGhader H; Hosseini SS; Sheikh Beig Goharrizi MA; Masoudi-Nejad A
Sci Rep; 2022 Apr; 12(1):5885. PubMed ID: 35393513
[TBL] [Abstract][Full Text] [Related]
40. Construction of CeRNA regulatory network based on WGCNA reveals diagnosis biomarkers for colorectal cancer.
Xiang J; Gao L; Jing HY; Liu YX; Wang HF; Chang ZW; Liu SH; Yu L; Wang GY
BMC Cancer; 2022 Sep; 22(1):991. PubMed ID: 36115953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
